Literature DB >> 6643656

Serum antibodies to enterotoxins produced by Staphylococcus aureus with special reference to enterotoxin F and toxic shock syndrome.

S Notermans, W J van Leeuwen, J Dufrenne, P D Tips.   

Abstract

The presence of antibodies to staphylococcal enterotoxins (enterotoxins A through F) in sera of healthy subjects (n = 567) and in sera of patients with toxic shock syndrome (n = 20) was determined. Furthermore, production of enterotoxins by Staphylococcus aureus isolated from humans was investigated. In 46, 86, 78, 41, 20, and 91% of the sera of healthy subjects, antibodies were found against enterotoxins A, B, C, D, E, and F, respectively. The high percentage of sera with antibodies against enterotoxin F correlated with the relatively high frequency of enterotoxin F-producing S. aureus isolated from humans (one-third of the isolates produced enterotoxin F). In patients with toxic shock syndrome, antibodies against enterotoxin F were not present or were present only at very low levels. An increase of antibodies after onset of the disease was observed in two of eight patients investigated. From the results, it can be concluded that only those humans who show low levels of antibodies are susceptible to toxic shock syndrome.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643656      PMCID: PMC272840          DOI: 10.1128/jcm.18.5.1055-1060.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome.

Authors:  P M Schlievert; M T Osterholm; J A Kelly; R D Nishimura
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

2.  Toxic shock syndrome: interaction of endotoxin and staphylococcal toxins.

Authors:  D Fumarola; G Miragliotta
Journal:  Infection       Date:  1981       Impact factor: 3.553

3.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

4.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

5.  A simple purification method for enterotoxin F produced by Staphylococcus aureus and some properties of the toxin.

Authors:  S Notermans; J B Dufrenne
Journal:  Antonie Van Leeuwenhoek       Date:  1982-12       Impact factor: 2.271

6.  Detection of circulating free and complexed staphylococcal antigens by enzyme-linked immunosorbent assay.

Authors:  J R Lentino; M W Rytel
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

7.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

8.  Precipitating antibodies against Staphylococcus aureus in serum from patients with staphylococcal osteomyelitis, investigated by means of quantitative immunoelectrophoretic methods.

Authors:  F Espersen; S A Hedström
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1982-06

9.  Detection of Staphylococcus aureus antibodies in patients with S. aureus infections and in normal persons, using solid phase radioimmunoassay.

Authors:  B Christensson; S A Hedström; G Kronvall
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1982-06

10.  Enterotoxin production by strains of Staphylococcus aureus isolated from clinical and non-clinical specimens with special reference to enterotoxin F and toxic shock syndrome.

Authors:  M P de Nooij; W J van Leeuwen; S Notermans
Journal:  J Hyg (Lond)       Date:  1982-12
View more
  8 in total

1.  Comparison of dissociation-enhanced lanthanide fluorescent immunoassays to enzyme-linked immunosorbent assays for detection of staphylococcal enterotoxin B, Yersinia pestis-specific F1 antigen, and Venezuelan equine encephalitis virus.

Authors:  D R Smith; C A Rossi; T M Kijek; E A Henchal; G V Ludwig
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Toxic shock syndrome toxin 1 (TSST-1) production by staphylococci isolated from goats and presence of specific antibodies to TSST-1 in serum and milk.

Authors:  J Valle; S Vadillo; S Piriz; E Gomez-Lucia
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

3.  Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1.

Authors:  B Christensson; P J Johansson; V A Oxelius
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

Review 4.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

5.  Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].

Authors:  S Takei; Y K Arora; S M Walker
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

6.  Staphylococcus aureus nasal carriage in rheumatoid arthritis: antibody response to toxic shock syndrome toxin-1.

Authors:  D Tabarya; W L Hoffman
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

7.  Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.

Authors:  P F Bonventre; M R Thompson; L E Adinolfi; Z A Gillis; J Parsonnet
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

8.  Increased levels of serum IgM antibody to staphylococcal enterotoxin B in patients with rheumatoid arthritis.

Authors:  T Origuchi; K Eguchi; Y Kawabe; I Yamashita; A Mizokami; H Ida; S Nagataki
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.